Key result
AI-ECG reliably identifies NSTEMI with ~0.80 AUROC across diverse clinical and ECG subgroups.
Why the study?
NSTEMI encompasses a heterogeneous spectrum of presentations with pronounced diagnostic uncertainty in early presenters and patients without overt ischemic ECG changes, and whether AI-ECG maintains stable performance across this diversity remained unclear.
Does artificial intelligence–enabled electrocardiography maintain robust diagnostic discrimination for NSTEMI across heterogeneous clinical and ECG-defined presentations and differentiate occlusive from non-occlusive NSTEMI in emergency department patients with suspected acute myocardial infarction?
Cohort (n=8,493)
Yes
Does artificial intelligence–enabled electrocardiography maintain robust diagnostic discrimination for NSTEMI across heterogeneous clinical and ECG-defined presentations and differentiate occlusive from non-occlusive NSTEMI in emergency department patients with suspected acute myocardial infarction?
AI-ECG provides consistent diagnostic discrimination for NSTEMI across diverse patient subgroups and shows higher score distributions in occlusive NSTEMI, supporting its utility as an early triage tool in the emergency department.
May support AI-ECG for early NSTEMI triage across subgroups; leaves open whether prospective trials will confirm clinical utility.
Background Non–ST-segment elevation myocardial infarction (NSTEMI) encompasses a heterogeneous spectrum of clinical and electrocardiographic presentations. Diagnostic uncertainty is particularly pronounced in early presenters and in patients without overt ischemic ECG changes. Whether artificial intelligence–enabled electrocardiography (AI-ECG) maintains stable performance across this diversity remains unclear. Purpose To evaluate the robustness of AI-ECG across diverse NSTEMI phenotypes and to explore score distribution according to occlusion status. Methods In the prospective, multicenter ROMIAE cohort of 8,493 emergency department patients with suspected acute myocardial infarction, NSTEMI cases were analyzed. AI-ECG generated continuous probability scores from initial 12-lead ECGs using prespecified thresholds.1 Discrimination was assessed using AUROC. Prespecified subgroup analyses examined performance across age, comorbidities (hypertension, diabetes, coronary artery disease, prior myocardial infarction, heart failure), ischemic ECG features, rhythm abnormalities (atrial fibrillation, bundle branch block), and early presentation (≤3 hours). AI-ECG score distributions were compared between occlusive and non-occlusive NSTEMI. Results AI-ECG demonstrated stable discrimination for NSTEMI (AUROC ~0.80 range) without systematic degradation across clinical or ECG-defined subgroups. Performance remained consistent in early presenters, in patients without overt ischemic ECG features, and in those with rhythm abnormalities. (Figure 1) AI-ECG scores showed a graded distribution within NSTEMI phenotypes, with higher median values observed in occlusive compared with non-occlusive NSTEMI. (Figure 2) This gradient was evident despite absence of ST-segment elevation, suggesting that AI-ECG captures ischemic signal patterns beyond conventional criteria. Conclusion In a prospective multicenter cohort, AI-ECG maintained robust diagnostic performance across heterogeneous NSTEMI presentations and demonstrated graded signal distribution according to occlusion status. These findings support AI-ECG as a time-zero triage adjunct capable of reducing diagnostic uncertainty in NSTEMI while reflecting underlying ischemic burden.Figure 1Figure 2
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) conducted a cohort in Non–ST-segment elevation myocardial infarction (NSTEMI) (n=8,493). Artificial intelligence–enabled electrocardiography (AI-ECG) was evaluated on Diagnostic discrimination for NSTEMI (AUROC ~0.80). AI-ECG demonstrated stable diagnostic discrimination for NSTEMI (AUROC ~0.80) across clinical and ECG-defined subgroups, with higher median scores in occlusive versus non-occlusive NSTEMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: